
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Lupus
Sec. Epidemiology of Lupus
Volume 3 - 2025 | doi: 10.3389/flupu.2025.1553510
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background. Post traumatic stress disorder (PTSD) is associated with traumatic brain injury (TBI) and autoimmune disease, including systemic lupus erythematosus (SLE). We sought to determine whether the association was related to only PTSD or the combination of PTSD and TBI.Methods. We studied rheumatic disease autoantibodies in a cohort of 40 patients, 20 of whom had TBI without PTSD and 20 had both PTSD and TBI. None had diagnosed rheumatic autoimmune disease. We also examined a cohort of 229 TBI patients, of whom 60% had PTSD, for diagnosis of rheumatic autoimmune disease.Results. Among the 20 subjects with PTSD and TBI, 8 had autoantibodies (1 each with anti-Ro (or SSA), anti-RNP and anti-RNP plus anti-dsDNA, the remainder with a positive ANA). Only 1 of 20 subjects with TBI alone had autoantibodies (p=0.0088 by Fisher's Exact test). In the cohort of 229 subjects, there were 92 with TBI but no PTSD, of whom 4 (4.3%) had a diagnosed rheumatic autoimmune disease. Of the 127 with TBI and PTSD, 17 (13.3%) had an autoimmune rheumatic disease (p=0.02 by Fisher's exact test).Conclusion. We found more autoantibodies in the sera of patients with TBI and PTSD thanbut not with in TBI alone. In addition, we found a 3-fold increased prevalence of autoimmune rheumatic disease in patients with TBI and PTSD compared to those with TBI alone. TBI is strongly associated with PTSD but we conclude that TBI does not contribute to the increased risk of autoimmune disease in PTSD.
Keywords: PTSD, Systemic lupus - erythematosus, autoimmune disease, Autoantibodies, Rhuematoid Arthritis
Received: 30 Dec 2024; Accepted: 28 Mar 2025.
Copyright: © 2025 Scofield, Lawrence, Kurien, Gross, Sorocco, Prodan and Lewis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
R. Hal Scofield, Oklahoma Medical Research Foundation, Oklahoma City, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.